Searching for just a few words should be enough to get started. If you need to make more complex queries, use the tips below to guide you.
Article type: Research Article
Authors: Ali Hosseini, Seyed; | Sobti, Ranbir Chander | Malekzadeh, Kianoosh | Singh, Shrawan Kumar | Joshi, Kusum
Affiliations: Department of Biotechnology, Panjab University, Chandigarh, India | Department of Medical Genetics, National Institute of Genetic Engineering and Biotechnology, Tehran, Iran | Department of Urology, Post Graduate of Medical Education and Research, Chandigarh, India | Department of Histopathology, Post Graduate of Medical Education and Research, Chandigarh, India
Note: [] Corresponding authors: Seyed Ali Hosseini and Ranbir Chander Sobti, Department of Biotechnology, Panjab University, Chandigarh, 160014, India. Tel.: +91 172 2541409; E-mail: [email protected]
Abstract: Introduction: Amongst the genitourinary cancers, carcinoma of the urinary bladder is one of the leading causes of death in India. Hypermethylation of the CpG islands of gene promoter is one of the earliest and most frequent epigenetic alterations leading to cancer as well as in its development. Several studies have suggested that tumour suppressor genes play a key role in the development of cancer. Methylation in the CDKN2A has been associated with various malignant diseases, but information with respect to urinary bladder cancer is lacking in north Indian population. Materials and methods: We analyzed the methylation of P16INK4a and P14ARF in 80 tissues and matched blood samples of patients suffering from bladder cancer and 80 blood samples of cancer-free individuals by MS-PCR. Results: In tissue and matched blood samples of bladder cancer patients, the incidence of P14ARF hypermethylation significantly increased (OR=0.31, 95%CI =0.12–0.8, P=0.01) and (OR=0.0, 95%CI=0.0–0.62, P=0.006) respectively with an increase in age. Clinicopathological analysis revealed that P14ARF hypermethylation in tissue and blood samples was significantly associated with invasive stage (⩾ T2) (OR=0.21, 95%CI = 0.08–0.51, P=0.0002) and (OR = 0.09, 95%CI = 0.03–0.37, P= 0.00001) respectively. Muscle invasive tumour stage (⩾T2) showed significant association with increased risk of P16INK4α promoter hypermethylation in tissue and blood samples of patients (OR = 0.38, 95%CI = 0.17–0.82, P= 0.01) and (OR = 0.13, 95%CI = 0.05–0.36, P= 0.00005) respectively. Conclusion: These results suggest that the CpG island hypermethylation status of the defined panel of genes may be a useful biomarker in patients suffering from bladder cancer.
Keywords: Bladder cancer, methylation, tumour suppressor gene, P14ARF, P16INK4a
DOI: 10.3233/DMA-2010-0716
Journal: Disease Markers, vol. 28, no. 6, pp. 361-368, 2010
IOS Press, Inc.
6751 Tepper Drive
Clifton, VA 20124
USA
Tel: +1 703 830 6300
Fax: +1 703 830 2300
[email protected]
For editorial issues, like the status of your submitted paper or proposals, write to [email protected]
IOS Press
Nieuwe Hemweg 6B
1013 BG Amsterdam
The Netherlands
Tel: +31 20 688 3355
Fax: +31 20 687 0091
[email protected]
For editorial issues, permissions, book requests, submissions and proceedings, contact the Amsterdam office [email protected]
Inspirees International (China Office)
Ciyunsi Beili 207(CapitaLand), Bld 1, 7-901
100025, Beijing
China
Free service line: 400 661 8717
Fax: +86 10 8446 7947
[email protected]
For editorial issues, like the status of your submitted paper or proposals, write to [email protected]
如果您在出版方面需要帮助或有任何建, 件至: [email protected]